JRF GLOBAL — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

JRF Global is an established, privately-held contract research organization offering a broad portfolio of regulatory testing services. Its core business is providing the necessary health and environmental safety studies required for market approval of pharmaceuticals (IND/NDA/ANDA), agrochemicals, biocides, and industrial chemicals. Leveraging its OECD GLP-accredited laboratories and scientific expertise, the company positions itself as a cost-effective and reliable partner for sponsors navigating complex global regulatory landscapes. Its service model is built on customized study protocols, project management, and competitive pricing compared to Western labs.

Drug Delivery

Technology Platform

Integrated contract research service platform offering non-clinical toxicology, DMPK, analytical chemistry, and environmental safety testing under OECD GLP standards.

Opportunities

Growing global demand for outsourced regulatory testing from pharma, agrochemical, and chemical industries, driven by R&D complexity and cost pressures.

Its cost-competitive model, leveraging OECD GLP-accredited labs in lower-cost regions, positions it favorably against Western CROs.

Expansion of in vitro alternative testing aligns with regulatory shifts away from animal studies.

Risk Factors

Faces intense competition from large global CROs and niche players.

Core business is exposed to regulatory and reputational risk if any study compliance or data integrity issues arise.

Revenue is susceptible to cyclical fluctuations in client R&D spending across its served industries.

Competitive Landscape

Operates in the highly fragmented global CRO market, competing with large public players (e.g., Labcorp, Charles River Laboratories) on service breadth and with smaller regional CROs on specialization and cost. Its key differentiator is offering a broad range of OECD GLP-compliant services at a competitive price point, supported by its multinational operational footprint.

More companies in Digital Health & Biotech SaaS →More companies in United States →